Study of the Safety and Efficacy of a Caffeine-based Antifibrosis Cream in Patients With Breast Cancer Undergoing Radiation Therapy
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Carcinoma Breast
Interventions: DRUG: Caffeine anhydrous 5% added to Lipoderm Cream Base.|OTHER: Lipoderm Cream Base
Sponsor: NYU Langone Health